Latest / Talking FACS / Non‑Abstinent Recovery: Harm Reduction as the Front Door to Healing
Transcript
- 0:00Welcome to Talking FACS, what you need to know about family,
- 0:03food, finance, and fitness.
- 0:06This nationally recognized, award-winning podcast is hosted by the University
- 0:11of Kentucky Family and Consumer Sciences Extension Program.
- 0:15Our educators share research knowledge with individuals, families,
- 0:19and communities to improve quality of life.
- 0:22Welcome to Talking FACS, where we share research-based information to help
- 0:26improve the quality of life for Kentuckians.
- 0:29I'm your host, Dr. Alex Elswick, Associate Professor and Extension Specialist
- 0:34for Substance Use Prevention and Recovery.
- 0:36As a reminder, our disclaimer, we're speaking today from our personal areas
- 0:39of expertise, and our views do not represent the official views of the University of Kentucky.
- 0:45Having the housekeeping out of the way, I'm honored and grateful and excited
- 0:50to introduce our guest for today, Alex Johansson.
- 0:52Alex is a second-year psychology PhD student at University of Kentucky,
- 0:58where her research focuses on developing treatments for substance use disorders,
- 1:02specifically cocaine and methamphetamine.
- 1:05And Alex was also recently featured in the UK Now periodical.
- 1:09So she's a star and we're so grateful she could make time for us.
- 1:13So Alex, thanks for being here. Oh, thank you for having me.
- 1:17And in particular, what we're talking about today is something that I'm very
- 1:20excited and passionate about, and that is harm reduction. And more specifically,
- 1:26we're talking about non-abstinent recovery.
- 1:29And so before we start getting into the meat and potatoes of non-abstinent recovery,
- 1:34I thought we might start by just addressing a couple of myths,
- 1:37because on its face, to some people, that just sounds like an oxymoron,
- 1:42non-abstinent recovery.
- 1:44So maybe I'll give you a couple of myths and you can tell me why they're mythology
- 1:49and not quite true. Sound good? That's great.
- 1:52Okay. So myth number one that I hear frequently in the general public and also
- 1:56kind of in the recovery community is that non-abstinent recovery is really just
- 2:02giving up and in particular giving up on abstinence. How would you respond to that?
- 2:07So when people hear non-abstinence, they think they assume that that means like encouraging drug use.
- 2:13In reality, non-absence really means recognizing that people can make meaningful
- 2:17progress toward health and wellness goals without being perfect.
- 2:21And we say this in just the broader healthcare space. So for diabetes or weight
- 2:25loss, people have goals and it's kind of incremental changes over time that
- 2:29they're encouraged to achieve to reach their ultimate goals.
- 2:32It's such a good example that I think makes it all more readily accessible for
- 2:37everybody to understand because weight loss is a struggle for so many people,
- 2:41especially in Kentucky.
- 2:42We know that like a third of the state is pre-diabetic or diabetic.
- 2:46And this is something that lots of people struggle with. And we recognize, as you've said, that.
- 2:52You know, maybe becoming a model on the front page of a fitness magazine isn't
- 2:56your goal, but maybe losing 10 or 15 pounds helps reduce the burden on your health. Exactly.
- 3:03Another myth that I hear frequently is that harm reduction and abstinence are opposites.
- 3:11That kind of, it's similar to what we said before, but that because harm reduction
- 3:15is sort of giving up on abstinence, that harm reduction and abstinence are opposites.
- 3:20How would you respond to that?
- 3:22I hear that a lot too. Harm reduction is not the opposite of recovery.
- 3:26It's really a front door to recovery. It's one of the most robust pathways in recovery.
- 3:31For example, people who use drugs who engage with strict service programs are
- 3:35more likely to access treatment.
- 3:38So recovery isn't one huge decision about drug use.
- 3:41It's really a bunch of small incremental decisions that people make as they
- 3:45navigate the resources that are available to them and try to build recovery capital.
- 3:49And recovery capital is really just the sum of all the resources,
- 3:53both internal and external, that people have access to to help start or continue
- 3:58their recovery journey.
- 4:00And that's really interesting when you say that harm reduction is not the opposite
- 4:05of recovery, but it's a front door to recovery, a robust pathway of recovery.
- 4:11What it brings to mind for me is that even people for whom their recovery is
- 4:17characterized by abstinence, complete abstinence today, for the majority of even those folks,
- 4:24they weren't completely abstinent the day that their recovery journey began.
- 4:29And even for those folks, most people experience recovery as nonlinear.
- 4:33So like fits and starts and three steps forward and two steps back.
- 4:37And so I think that makes a lot of sense.
- 4:41And then I guess relatedly, but the third myth that I hear a lot is that recovery
- 4:45is abstinence, that abstinence is recovery, that recovery is abstinence,
- 4:49and anything else isn't recovery.
- 4:53I think that's probably the prevailing view in the general public too.
- 4:56What would you say to that?
- 4:59So abstinence is really focusing on what you aren't doing, right?
- 5:03And recovery is really focusing on the things that you can do instead.
- 5:07So instead of saying something like, stop using and life will get better,
- 5:11we can say, try to improve recovery capital.
- 5:14So try to improve the resources you have access to, focus on your own growth,
- 5:19focus on building your social networks, finding supports, and life will get better as a result.
- 5:25And recovery is enabled through that process.
- 5:28So most people take, as you said, kind of a non-abstinence pathway.
- 5:32It's a process that's not this one moment or this one decision.
- 5:36And we also know that substance use disorders are chronic and they're relapsing.
- 5:41So even those who want to ultimately take an abstinence pathway do have periods of non-abstinence.
- 5:48So, again, recovery is really this process and making room for non-abstinence,
- 5:53as we talk about recovery is really highlighting recovery as a process.
- 5:59Yeah, I was honing in on the same word as you there, that word process,
- 6:04that recovery is never an event for anyone.
- 6:10That it is a process kind of by definition, even if it meant it's been characterized
- 6:15by abstinence all along, for everyone, recovery is a process.
- 6:19Okay. Okay. So that's helpful myth-busting, but we can also use a little bit
- 6:24of a refresher on harm reduction.
- 6:25And we have a couple of other Talking FACS episodes that we can link in the
- 6:30description notes to give some background on harm reduction.
- 6:34But for context, for listeners, What do we mean when we say harm reduction?
- 6:38Yeah, so harm reduction, it's both a philosophy and a tool. And at its core,
- 6:42it's really just accepting that drug use has always been a part of our world.
- 6:45And instead of judging it, condemning it, assigning some moral value to it,
- 6:51it accepts that it's a reality.
- 6:54And the goal is to really meet people where they are and to try to reduce risks
- 6:58associated with substance use.
- 7:00Now, we usually talk about it in the context of substance use,
- 7:02But it really is something that we see pretty frequently just in our healthcare
- 7:07system and our public health guidance.
- 7:09For example, wearing sunscreen when you go out to tan or you go to the beach
- 7:12to help reduce the risk of skin cancer and things like that.
- 7:16I always use the example that, again, these are not the express views of the
- 7:20University of Kentucky, but Coke Zero has like the new formulation of Coke Zero is so good.
- 7:25And there is no positive health benefit to me continuing to drink any kind of
- 7:31soft drink. It only adds to the public health burden.
- 7:34But dang it, I want to taste a Coke. And so instead of drinking full sugar Coke,
- 7:38I drink a Coke Zero. Right.
- 7:39And as much as it's like a silly example, I do think those examples help bring
- 7:44to light that abstinence isn't always the answer to a potentially harmful health
- 7:50behavior, that sometimes harm reduction is the answer that's best for us.
- 7:55And so when we apply harm reduction to substance use disorder,
- 8:00then what does that look like?
- 8:01Right. So harm reduction acknowledges that substance use disorders,
- 8:05they're chronic, they're relapsing, it's not acute.
- 8:07And they are characterized by continuing to use drugs despite adverse consequences.
- 8:13And the goal, as we said earlier, is to really reduce the severity of those
- 8:17consequences or eradicate them altogether.
- 8:19And so in that context, what does recovery then look like from substance use disorder?
- 8:25Right. So recovery, as we've said many times during this conversation,
- 8:30is a process that is not a standalone event.
- 8:33There are several different, infinite different paths to recovery that people can choose to take.
- 8:38And recovery can look different for different people. Some people want an abstinence-only
- 8:44outcome for substance use, and then some people are looking to simply reduce.
- 8:48And then some people are also really interested in just building up their access
- 8:53to other resources available to them. In other words, building up their recovery
- 8:57capital to improve quality of life.
- 8:59Has research shown whether or not abstinence or non-abstinence is a safer approach?
- 9:06So abstinence is the safest option. But there is some evidence to suggest that
- 9:11reductions in use can still confer benefits and harm reduction accepts that both can be true.
- 9:17So there's actually a growing body of research that highlighted the benefits
- 9:21of reducing alcohol use specifically.
- 9:24And the FDA now recognizes partial reductions in drinking as an endpoint for
- 9:29clinical trials for alcohol.
- 9:31And in other words, I'm just saying alcohol or drinking less is better for your
- 9:35health overall. You don't need to quit completely to experience benefits.
- 9:40Again, quitting completely is probably the best for your health.
- 9:43It's the safest option. But there is a middle ground.
- 9:46It's just really interesting, given the recent guidance from the Surgeon General
- 9:51and just the broader academic community around alcohol, where we used to say
- 9:55there was a safe amount of alcohol to drink or maybe that a glass of red wine
- 9:59was good for cardiovascular health.
- 10:01And now the more recent guidance seem to suggest that really any alcohol consumption,
- 10:06is associated with with harm, certainly the potential for harms.
- 10:10And so even though we're seeing people drink less and less, I think,
- 10:15your average listener who might enjoy responsibly drinking alcohol likes to
- 10:19hear the fact that maybe they don't have to entirely give up on alcohol and
- 10:24that reductions come with health benefits as well.
- 10:28And we're doing some of that work specifically at the University of Kentucky.
- 10:32Is that right? Exploring some of those reductions in use rather than just abstinence alone?
- 10:37Yes. And my mentor, Phil Stoops, has been doing a lot of this work in the cocaine space.
- 10:41So we've done some recent research through a clinical trial showing that reductions
- 10:46in cocaine use improved cardiovascular health, immune system function,
- 10:51overall quality of life, and possibly cognition.
- 10:55So that's really interesting work. It's fascinating work, and it's fascinating
- 10:59in part because the opioid epidemic receives a lot of the media attention, but we know in Kentucky,
- 11:06and we can link a Talking FACS episode to this as well below,
- 11:11that there are twin epidemics in the state of Kentucky, and that what gets lesser
- 11:15attention is the increase in stimulant use.
- 11:18And so this, I think, is really timely and relevant as we explore some of the
- 11:22benefits and reductions in stimulant use.
- 11:25Before we close out, I want to make sure. So I think it's, I think it's probably
- 11:29pretty much immediately obvious to most listeners,
- 11:32why reductions in use are valuable on its face, that reducing,
- 11:37that using less drugs or fewer drugs is, is better.
- 11:40It's going to have fewer negative health, adverse outcomes, that sort of thing.
- 11:45That makes sense. But still, I think sometimes making the connection between
- 11:49reduced drug use and recovery is, is hard for people because it's not as easy
- 11:54for them to connect in their minds as complete abstinence and recovery.
- 11:59So I want to think just a little bit more about how non-abstinence helps in recovery.
- 12:06And so you mentioned recovery capital. Can you talk a little bit more about
- 12:09the relationship among those things?
- 12:11Yes. So I kind of like to think about recovery capital as a little bit of a bridge here.
- 12:17And it basically helps people connect where they are now with where they want
- 12:20to be in their recovery journey.
- 12:22And we kind of alluded to this earlier, but there's three domains to recovery
- 12:27capital you can kind of think about. One is personal, so things like physical health coping skills.
- 12:33A second is family or social relationships, supportive recovery efforts.
- 12:38And then the third is community. So societal supports, whether that's stable
- 12:41housing, access to transportation, access to treatment, things like that.
- 12:46So by reducing use, that allows people to,
- 12:50build recovery capital, to gain new skills, to help foster new connections,
- 12:55find access to resources in their communities that are going to help them continue
- 12:59to achieve their goal, whether that is an abstinence or a non-abstinence.
- 13:04Recovery outcome. Thank you. Okay. That helps make the connection there.
- 13:08Before we completely close out, I also want to make sure that the implications
- 13:12of this are well understood because I think there are some really important
- 13:16implications here. So from a research perspective, why does this work matter?
- 13:22Yeah, this work is really important from a medications development standpoint.
- 13:28And what I mean by that is that it helps inform what we choose as endpoints
- 13:32or our main outcomes that we're measuring in our research studies.
- 13:35So a medication that may not result in complete abstinence may still contribute
- 13:40to substantial reductions in use, which again may be linked to overall well-being
- 13:45or improvements in quality of life.
- 13:47And as a field, we've overlooked these outcomes for a long time.
- 13:49We've only focused on abstinence and arguably to the detriment of treatment
- 13:54development for substance use disorders. So if we take a little bit more of
- 13:57a harm reduction lens to this.
- 13:59It may help facilitate new inroads, more treatment options. Right now,
- 14:03I know you mentioned stimulants earlier. There are no FDA-approved medications
- 14:07for stimulant use disorders, either for cocaine or for methamphetamine.
- 14:11So that's an active area of research right now. I love that.
- 14:14And I love the way you framed that applying this harm reduction lens may help
- 14:18facilitate new inroads because it makes me think about,
- 14:21how much broader the umbrella of well-being and recovery is when it isn't just
- 14:26about abstinence, when it's really about trying to accomplish all these other
- 14:29forms of improving quality of life.
- 14:32And so then from a public health perspective, why does this work matter?
- 14:37Yeah. So again, I kind of alluded to this earlier, but substance use disproportionately
- 14:41impacts communities in Kentucky compared to other states.
- 14:44And we talk a lot about the opioid crisis, but actually according to the 2025
- 14:48Kentucky drug overdose fatality report, methamphetamine was the most frequently
- 14:52identified drug in overdose death toxicology reports actually ahead of fentanyl.
- 14:59So, to me, that says we urgently need treatments for standard use disorders
- 15:03and advancing non-absent outcomes will help us achieve this goal while also
- 15:08reducing stigma around substance use disorder treatment and recovery.
- 15:11Fascinating. And I'll just underscore one more time what you've just said,
- 15:14that in the latest Kentucky Drug Overdose Fatality Report, that methamphetamine
- 15:19was the most frequently identified drug per toxicology results in overdose deaths ahead of fentanyl.
- 15:25And that's really shocking, I think, given the disproportionate amount of attention
- 15:29that fentanyl's received.
- 15:31That's really fascinating. So Alex, thank you for your really important work.
- 15:34Thank you for taking the time to be our guest today. And I hope you'll come
- 15:38back and tell us more about some of your future work.
- 15:41Thank you so much for having me. If you're just tuning in, you're listening
- 15:45to Talking FACS, presented by Family and Consumer Sciences Extension in the
- 15:49Martin-Gatton College of Agriculture, Food, and Environment at the University of Kentucky.
- 15:54Talking FACS is available wherever you find your favorite podcast.
- 15:58Thank you for listening to Talking FACS. We deliver programs focusing on nutrition,
- 16:03health, resource management, family development, and civic engagement.
- 16:08If you enjoyed today's podcast, have a question, or a show topic idea,
- 16:12leave a like and a comment on Facebook at UKFCSEXT.
- 16:18Or send us an email at UKFCSEXT at UKY.edu.
- 16:25Visit us online at fcs.uky.edu to learn more about the University of Kentucky
- 16:31Family and Consumer Sciences Extension Program or contact your local Extension
- 16:36agent for Family and Consumer Sciences.
- 16:38We build strong families. We build Kentucky. It starts with us.